According to Antu Biotech's announcement, the company and its wholly-owned subsidiary Sikun Biotech and the second-level subsidiary Zhengzhou Biaoyuan recently received 4 medical device registration certificates issued by the State Drug Administration, namely genetic sequencer, Mycoplasma pneumoniae antigen test kit, EBV capsid antigen IgG antibody test kit, and EB virus antibody quality control product II. The registration certificates are all valid for 5 years. Obtaining the above registration certificate further enriches the company's product menu, effectively complements existing testing products, and has little impact on the company's operating performance in the short term.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.